BioCryst Awarded BCX4430 Advanced Development Contract

March 31, 2015 10:59 AM

17 0

BARDA Awards NDA Enabling CMC & Non-Clinical Toxicology Studies Contract for BCX4430

RESEARCH TRIANGLE PARK, N.C., March 31, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services'Office of the Assistant Secretary for Prepared...

Read more

To category page